Travel to the USA, speak to the clinicians. The answer lies there.
I am not disputing CSL is not a good business - there is a price for any businesses - and with what Shire/Takeda are doing
Go read Takedas last Quarterly update and come back with what you find.
Also ask patients do they want frequeny treatment each week with CSL in a clinic? Or do they want infrequency treatment in there own home, which is what Shire does? ... ask the customer ... the answer is obvous.
CSL Chart, page-638
-
- There are more pages in this discussion • 472 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$286.28 |
Change
1.180(0.41%) |
Mkt cap ! $138.6B | |||
| Open | High | Low | Value | Volume |
| $285.01 | $287.35 | $283.85 | $246.0M | 861.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2265 | $285.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $286.28 | 4885 | 3 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |